Last update 27 Mar 2025

Nebratamig

Overview

Basic Info

Drug Type
Tetraspecific antibody
Synonyms
GNC-035 quadr-specific antibody(Sichuan Baili Pharmaceutical Co., Ltd.), GNC-035
Action
inhibitors, antagonists
Mechanism
4-1BB inhibitors(Tumor necrosis factor receptor superfamily member 9 inhibitors), CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Hodgkin's lymphoma refractoryPhase 2
China
01 Nov 2023
Chronic Lymphocytic LeukemiaPhase 2
China
16 Aug 2023
Acute Lymphoblastic LeukemiaPhase 1
China
09 Feb 2022
Acute Myeloid LeukemiaPhase 1
China
09 Feb 2022
Diffuse Large B-Cell LymphomaPhase 1
China
09 Feb 2022
Follicular LymphomaPhase 1
China
09 Feb 2022
Mantle-Cell LymphomaPhase 1
China
09 Feb 2022
Philadelphia positive acute lymphocytic leukaemiaPhase 1
China
09 Feb 2022
Philadelphia positive acute lymphocytic leukaemiaPhase 1
China
09 Feb 2022
Pre B-cell acute lymphoblastic leukemiaPhase 1
China
09 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free